Spruce Biosciences (SPRB) Short Interest Ratio & Short Volume $0.46 +0.02 (+4.59%) (As of 10/4/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Spruce Biosciences Short Interest DataSpruce Biosciences (SPRB) has a short interest of 249,000 shares. This marks a -1.23% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.6, indicating that it would take 0.6 days of the average trading volume of 455,880 shares to cover all short positions.Current Short Interest249,000 sharesPrevious Short Interest252,100 sharesChange Vs. Previous Month-1.23%Dollar Volume Sold Short$115,859.70Short Interest Ratio0.6 Days to CoverLast Record DateSeptember 15, 2024Outstanding Shares41,155,000 sharesPercentage of Shares Shorted0.61%Today's Trading Volume163,404 sharesAverage Trading Volume455,880 sharesToday's Volume Vs. Average36% Short Selling Spruce Biosciences? Sign up to receive the latest short interest report for Spruce Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSPRB Short Interest Over TimeSPRB Days to Cover Over TimeSPRB Percentage of Float Shorted Over Time Ad Crypto 101 MediaNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since they first opened to investors. Wall Street is finally embracing crypto. But most investors are missing the real goldmine… Go here to discover the crypto that's about to leave Wall Street in the dust. Spruce Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/15/2024249,000 shares $115,859.70 -1.2%N/A0.6 $0.47 8/31/2024252,100 shares $117,150.87 +22.7%N/A0.6 $0.46 8/15/2024205,400 shares $90,355.46 +52.2%N/A0.4 $0.44 7/31/2024135,000 shares $69,795.00 -23.6%N/A0.3 $0.52 7/15/2024176,800 shares $102,508.64 -28.7%N/A0.4 $0.58 6/30/2024248,100 shares $128,441.37 +103.9%N/A0.5 $0.52 Get the Latest News and Ratings for SPRB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Spruce Biosciences and its competitors with MarketBeat's FREE daily newsletter. 6/15/2024121,700 shares $79,068.49 +202.0%N/A0.2 $0.65 5/31/202440,300 shares $29,866.33 -67.3%N/A0 $0.74 5/15/2024123,300 shares $98,640.00 -42.8%N/A0.1 $0.80 4/30/2024215,500 shares $152,574.00 +31.4%1.0%0.2 $0.71 4/15/2024164,000 shares $115,734.80 -48.8%0.7%0.1 $0.71 3/31/2024320,400 shares $251,802.36 +69.3%1.5%0.3 $0.79 3/15/2024189,300 shares $152,954.40 +461.7%N/A0.2 $0.81 2/29/202433,700 shares $168,500.00 -33.0%0.2%0.1 $5.00 2/15/202450,300 shares $254,518.00 +17.3%0.3%0.2 $5.06 1/31/202442,900 shares $157,014.00 +117.8%N/A0.2 $3.66 1/15/202419,700 shares $48,856.00 -74.4%N/A0.1 $2.48 12/31/202377,000 shares $225,610.00 +64.5%N/A0.4 $2.93 12/15/202346,800 shares $77,688.00 -10.5%N/A0.3 $1.66 11/30/202352,300 shares $73,220.00 -24.0%N/A0.4 $1.40 11/15/202368,800 shares $79,120.00 +94.4%N/A0.6 $1.15 10/31/202335,400 shares $40,356.00 +49.4%N/A0.4 $1.14 10/15/202323,700 shares $37,683.00 -38.1%N/A0.3 $1.59 9/30/202338,300 shares $86,558.00 -53.4%N/A0.5 $2.26 9/15/202382,100 shares $201,966.00 +203.0%N/A1.1 $2.46 8/31/202327,100 shares $60,975.00 -14.0%N/A0.4 $2.25 8/15/202331,500 shares $68,040.00 -70.4%N/A0.3 $2.16 7/31/2023106,500 shares $239,625.00 +31.5%N/A0.8 $2.25 7/15/202381,000 shares $167,670.00 -16.3%N/A0.6 $2.07 6/30/202396,800 shares $208,120.00 +497.5%N/A0.6 $2.15 6/15/202316,200 shares $38,232.00 -96.6%N/A0.1 $2.36 5/31/2023470,900 shares $1.14 million -59.1%N/A2.9 $2.43 5/15/20231,150,000 shares $2.51 million -12.9%N/A6.6 $2.18 4/30/20231,320,000 shares $2.72 million -6.4%N/A7 $2.06 4/15/20231,410,000 shares $2.74 million +16.5%N/A6.5 $1.94 3/31/20231,210,000 shares $2.67 million +15.2%N/A2.6 $2.21 3/15/20231,050,000 shares $2.37 million -3.7%N/A0.7 $2.26 2/28/20231,090,000 shares $2.47 million +30.0%N/A0.7 $2.27 2/15/2023838,400 shares $2.29 million +1.6%13.6%0.6 $2.73 1/31/2023825,400 shares $2.43 million -31.8%6.8%0.6 $2.95Crypto Crash Ahead? (27 Experts Weigh In) (Ad)Donald Trump and his team just announced a brand new crypto project... They believe right now could be the perfect buying opportunity… And you have the chance to be a part of it! Claim your free ticket to the event now… 1/15/20231,210,000 shares $3.34 million +77.1%10.0%0.9 $2.76 12/30/2022683,100 shares $749,633.94 +16.1%5.6%0.5 $1.10 12/15/2022588,600 shares $588,600.00 +17.5%4.9%9.7 $1.00 11/30/2022500,900 shares $550,990.00 +52.3%4.1%9.3 $1.10 11/15/2022328,900 shares $345,345.00 +23.2%2.7%6.4 $1.05 10/31/2022267,000 shares $296,370.00 +211.9%2.2%7.9 $1.11 10/15/202285,600 shares $97,584.00 +40.1%0.7%2.6 $1.14 9/30/202261,100 shares $83,707.00 -19.5%0.5%2.2 $1.37 9/15/202275,900 shares $132,825.00 +22.0%0.6%1.7 $1.75 8/31/202262,200 shares $136,218.00 -13.6%0.5%1 $2.19 8/15/202272,000 shares $154,800.00 -31.8%0.6%0.5 $2.15 7/31/2022105,600 shares $195,360.00 +16.3%0.9%0.7 $1.85 7/15/202290,800 shares $171,612.00 -26.7%0.8%0.5 $1.89 6/30/2022123,900 shares $215,586.00 -71.2%1.0%0.7 $1.74 6/15/2022429,700 shares $687,520.00 +2.8%3.6%2.3 $1.60 5/31/2022417,900 shares $651,924.00 +8.2%3.5%2.2 $1.56 5/15/2022386,200 shares $525,232.00 -0.5%3.2%3.1 $1.36 4/30/2022388,300 shares $683,408.00 +2.5%3.5%2.8 $1.76 4/15/2022378,700 shares $802,844.00 +21.3%3.4%2.2 $2.12 3/31/2022312,100 shares $627,321.00 -5.1%3.5%1 $2.01 3/15/2022328,700 shares $608,095.00 -17.8%4.6%0.2 $1.85 2/28/2022399,900 shares $907,773.00 -4.4%5.6%0.1 $2.27 2/15/2022418,300 shares $962,090.00 -7.6%5.9%0.1 $2.30 1/31/2022452,600 shares $1.15 million -10.5%6.4%0.1 $2.54 1/15/2022505,400 shares $1.73 million -58.2%6.4%0.1 $3.43 12/31/20211,210,000 shares $5.40 million +78.7%17.1%0.3 $4.46 12/15/2021677,300 shares $1.69 million +28.4%9.6%0.2 $2.50 11/30/2021527,700 shares $1.36 million +10.8%7.5%3.9 $2.58 11/15/2021476,200 shares $2.09 million -0.7%6.8%4.4 $4.39 10/29/2021479,500 shares $2.28 million +2.0%6.8%7.7 $4.76 10/15/2021470,100 shares $2.11 million -3.0%6.0%9.6 $4.48 9/30/2021484,700 shares $2.91 million -10.5%6.2%11.2 $6.01 9/15/2021541,500 shares $3.91 million +1.3%7.0%10.3 $7.22 8/31/2021534,700 shares $4.10 million +0.6%6.9%8.7 $7.67 8/13/2021531,500 shares $4.08 million +9.3%6.9%8.9 $7.67 7/30/2021486,400 shares $4.48 million -1.6%6.3%6.9 $9.21 7/15/2021494,100 shares $4.91 million -3.1%6.4%6.1 $9.94 6/30/2021510,100 shares $5.72 million +5.6%6.6%6.4 $11.21 6/15/2021483,300 shares $5.62 million +6.5%6.2%6.8 $11.63 5/28/2021454,000 shares $6.42 million -1.9%5.9%6.4 $14.13 5/14/2021462,800 shares $6.76 million +3.2%6.4%6.7 $14.60 4/30/2021448,500 shares $7.83 million -4.6%6.2%7.9 $17.46 4/15/2021470,100 shares $7.46 million +9.9%6.5%9.6 $15.87 3/31/2021427,800 shares $6.51 million +9.1%5.9%9.5 $15.21 3/15/2021392,300 shares $10.12 million +0.7%5.4%5.9 $25.79 2/26/2021389,600 shares $8.26 million +3.3%5.4%6.2 $21.21 2/12/2021377,300 shares $8.05 million -1.4%5.2%5.8 $21.34 1/29/2021382,500 shares $7.68 million -3.8%6.2%5 $20.08 1/15/2021397,400 shares $9.41 million No Change6.4%4.7 $23.69 SPRB Short Interest - Frequently Asked Questions What is Spruce Biosciences' current short interest? Short interest is the volume of Spruce Biosciences shares that have been sold short but have not yet been closed out or covered. As of September 15th, investors have sold 249,000 shares of SPRB short. Learn More on Spruce Biosciences' current short interest. What is a good short interest ratio for Spruce Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SPRB shares currently have a short interest ratio of 1.0. Learn More on Spruce Biosciences's short interest ratio. Is Spruce Biosciences' short interest increasing or decreasing? Spruce Biosciences saw a decline in short interest in September. As of September 15th, there was short interest totaling 249,000 shares, a decline of 1.2% from the previous total of 252,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Spruce Biosciences' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Spruce Biosciences: Eagle Pharmaceuticals, Inc. (3.07%), OptiNose, Inc. (6.16%), CASI Pharmaceuticals, Inc. (3.78%), Cellectar Biosciences, Inc. (4.67%), Genenta Science S.p.A. (0.03%), Adlai Nortye Ltd. (0.03%), Eupraxia Pharmaceuticals Inc. (0.39%), Spero Therapeutics, Inc. (0.71%), BioVie Inc. (3.65%), DBV Technologies S.A. (0.32%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($6.15 billion), Charter Communications, Inc. ($4.04 billion), Paychex, Inc. ($2.77 billion), Nu Holdings Ltd. ($2.71 billion), Cencora, Inc. ($2.34 billion), Aptiv PLC ($2.18 billion), Tractor Supply ($2.07 billion), International Paper ($2.01 billion), AppLovin Co. ($1.95 billion), and Moderna, Inc. ($1.89 billion). View all of the most shorted stocks. What does it mean to sell short Spruce Biosciences stock? Short selling SPRB is an investing strategy that aims to generate trading profit from Spruce Biosciences as its price is falling. SPRB shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Spruce Biosciences? A short squeeze for Spruce Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SPRB, which in turn drives the price of the stock up even further. How often is Spruce Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SPRB, twice per month. The most recent reporting period available is September, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Eagle Pharmaceuticals Short Interest Data OptiNose Short Interest Data CASI Pharmaceuticals Short Interest Data Cellectar Biosciences Short Interest Data Genenta Science Short Interest Data Adlai Nortye Short Interest Data Eupraxia Pharmaceuticals Short Interest Data Spero Therapeutics Short Interest Data BioVie Short Interest Data DBV Technologies Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SPRB) was last updated on 10/6/2024 by MarketBeat.com Staff From Our PartnersThe panic button has already been pressedIf you missed it, my emergency election broadcast is now available on replay.Porter & Company | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredAI Expert Reveals New PickEveryone’s talking about AI right now, but I’ve been talking about it for years. And now I’ve just released...Brownstone Research | SponsoredNo matter the outcome of the election, it could be a death sentence for your wealth...In today's financial landscape, many investors are feeling disillusioned and disappointed with traditional inv...Allegiance Gold | SponsoredGolden Equation: Volatility = OpportunityWhen the market swings wildly, most investors panic… But it doesn't have to be this way. You see, when t...Prosper Trading Academy | SponsoredJeff Bezos Just Humiliated Elon MuskThe Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next...InvestorPlace | SponsoredWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)The Dow recently shed nearly 1,000 points in a single day… Big tech stocks are getting slaughtered… And ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spruce Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Spruce Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
